D.A. Davidson & Co’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-4,300
| Closed | -$230K | – | 1156 |
|
|
2017
Q4 | $230K | Hold |
4,300
| – | – | ﹤0.01% | 958 |
|
|
2017
Q3 | $256K | Sell |
4,300
-50
| -1% | -$2.98K | 0.01% | 914 |
|
|
2017
Q2 | $343K | Buy |
4,350
+100
| +2% | +$7.89K | 0.01% | 735 |
|
|
2017
Q1 | $352K | Sell |
4,250
-700
| -14% | -$58K | 0.01% | 724 |
|
|
2016
Q4 | $392K | Hold |
4,950
| – | – | 0.01% | 734 |
|
|
2016
Q3 | $346K | Hold |
4,950
| – | – | 0.01% | 755 |
|
|
2016
Q2 | $192K | Buy |
4,950
+150
| +3% | +$5.82K | 0.01% | 859 |
|
|
2016
Q1 | $194K | Hold |
4,800
| – | – | 0.01% | 855 |
|
|
2015
Q4 | $425K | Buy |
+4,800
| New | +$425K | 0.01% | 590 |
|